Gadeta Overview
- Founded
- 2015
- Status
- Private
- Employees
- 37
- Latest Deal Type
- Corporate
- Investors
- 4
Gadeta General Information
Description
Developer of innovative immunotherapies designed to treat cancer effectively. The company's innovative immunotherapies are based on the discoveries regarding the role of yo T cell receptors (TCR's) in the broad recognition of hematological and solid tumor cells and their potential use for the treatment of advanced malignancies, enabling healthcare institutions and cancer patients to eradicate both hematological and solid tumors lowering the chances of cancer.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Yalelaan 62
- 3584 CM Utrecht
- Netherlands
+31 085 000 0000
Gadeta Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Corporate | 19-Jul-2018 | 00.000 | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series A) | 29-Mar-2016 | 00.000 | 00.000 | Completed | Startup | |
| 1. Seed Round | Completed | Startup |
Gadeta Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of innovative immunotherapies designed to treat cancer effectively. The company's innovative immunotherapies a
Biotechnology
Utrecht, Netherlands
37
As of 2020
00.000
000000000000
00.000
0000000
dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui
0000 000000000
Philadelphia, PA
00
As of 0000
00000
00000000000
00000
00000000
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor
0000000000000
Gaithersburg, MD
00
As of 0000
00000
0000
0000-00-00
00000000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialGadeta Competitors (21)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Carisma Therapeutics | Venture Capital-Backed | Philadelphia, PA | 00 | 00000 | 00000000000 | 00000 |
| 000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
| 0000 000000000000 | Formerly VC-backed | Cambridge, MA | 000 | 00000 | 00000000 | 00000 |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 0000000 | Formerly VC-backed | Tübingen, Germany | 000 | 00.000 | 00000000 | 00.000 |
Gadeta Executive Team (7)
Gadeta Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Giovanni Mariggi Ph.D | Medicxi | Board Member | 000 0000 |
| Michèle Ollier MD | Medicxi | Board Member | 000 0000 |
| Oscar Schoots Ph.D | Utrecht Holdings | Board Member | 000 0000 |
| Peter Emtage | Gadeta | Board Member | 000 0000 |
Gadeta Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialGadeta Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Kite Pharma | Corporation | Majority | 000 0000 | 000000 0 | |
| Baxalta Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Medicxi | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Utrecht Holdings | Venture Capital | Minority | 000 0000 | 000000 0 |